- Home
- Publications
- Publication Search
- Publication Details
Title
Viral infections in the biologic therapy era
Authors
Keywords
-
Journal
Expert Review of Anti-Infective Therapy
Volume -, Issue -, Pages 1-11
Publisher
Informa UK Limited
Online
2018-09-09
DOI
10.1080/14787210.2018.1521270
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk of hepatitis B virus reactivation in patients treated with ibrutinib
- (2018) Sarah P. Hammond et al. BLOOD
- ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Introduction)
- (2018) M. Fernández-Ruiz et al. CLINICAL MICROBIOLOGY AND INFECTION
- ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Cell surface receptors and associated signaling pathways)
- (2018) J. Aguilar-Company et al. CLINICAL MICROBIOLOGY AND INFECTION
- ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid or myeloid cells surface antigens [II]: CD22, CD30, CD33, CD38, CD40, SLAMF-7 and CCR4)
- (2018) L. Drgona et al. CLINICAL MICROBIOLOGY AND INFECTION
- ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents)
- (2018) J.W. Baddley et al. CLINICAL MICROBIOLOGY AND INFECTION
- ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors)
- (2018) K.L. Winthrop et al. CLINICAL MICROBIOLOGY AND INFECTION
- ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Intracellular signaling pathways: tyrosine kinase and mTOR inhibitors)
- (2018) M. Reinwald et al. CLINICAL MICROBIOLOGY AND INFECTION
- ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Immune checkpoint inhibitors, cell adhesion inhibitors, sphingosine-1-phosphate receptor modulators and proteasome inhibitors)
- (2018) G. Redelman-Sidi et al. CLINICAL MICROBIOLOGY AND INFECTION
- ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52)
- (2018) M. Mikulska et al. CLINICAL MICROBIOLOGY AND INFECTION
- Vaccine profile of herpes zoster (HZ/su) subunit vaccine
- (2017) Anthony L. Cunningham et al. Expert Review of Vaccines
- Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions
- (2017) Rohit Loomba et al. GASTROENTEROLOGY
- Anti-PD-1/PD-L1 therapy for infectious diseases: learning from the cancer paradigm
- (2017) Martin Rao et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Active CMV infection in two patients with multiple sclerosis treated with alemtuzumab
- (2017) Marinella Clerico et al. Multiple Sclerosis Journal
- The Risk of Progressive Multifocal Leukoencephalopathy in the Biologic Era
- (2017) Eamonn S. Molloy et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Active CMV infection in two patients with multiple sclerosis treated with alemtuzumab
- (2017) Marinella Clerico et al. Multiple Sclerosis Journal
- Real-world comparative risks of herpes virus infections in tofacitinib and biologic-treated patients with rheumatoid arthritis
- (2016) Jeffrey R Curtis et al. ANNALS OF THE RHEUMATIC DISEASES
- Idelalisib in the management of lymphoma
- (2016) C. Y. Cheah et al. BLOOD
- The herpes zoster subunit vaccine
- (2016) Anthony L. Cunningham EXPERT OPINION ON BIOLOGICAL THERAPY
- The safety of anti PD-1 therapeutics for the treatment of melanoma
- (2016) Egle Ramelyte et al. Expert Opinion On Drug Safety
- Detection of cases of progressive multifocal leukoencephalopathy associated with new biologicals and targeted cancer therapies from the FDA’s adverse event reporting system
- (2016) Dennis W. Raisch et al. Expert Opinion On Drug Safety
- Immunogenicity of Influenza Vaccine for Patients with Inflammatory Bowel Disease on Maintenance Infliximab Therapy
- (2016) Jennifer deBruyn et al. INFLAMMATORY BOWEL DISEASES
- Use of tumor necrosis factor (TNF) inhibitors in patients with HIV/AIDS
- (2016) Stephanie M. Gallitano et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5)
- (2016) Vincent Mallet et al. LANCET INFECTIOUS DISEASES
- BK virus nephropathy in renal transplant recipients
- (2016) Jagadish S Jamboti NEPHROLOGY
- Infectious Complications With the Use of Biologic Response Modifiers in Infants and Children
- (2016) H. Dele Davies et al. PEDIATRICS
- Role of mTOR inhibitors for the control of viral infection in solid organ transplant recipients
- (2016) Julio Pascual et al. Transplant Infectious Disease
- Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapy
- (2016) Man Fai Law et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Infections with biological therapy: strategies for risk minimization in tropical and developing countries
- (2016) Carlos E. Pérez-Díaz et al. Journal of Infection in Developing Countries
- Reduced Incidence of Cytomegalovirus Infection in Kidney Transplant Recipients Receiving Everolimus and Reduced Tacrolimus Doses
- (2015) H. Tedesco- Silva et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Risk of infection with biologic antirheumatic therapies in patients with rheumatoid arthritis
- (2015) Manjari Lahiri et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Infection risk associated with anti-TNF-α agents: a review
- (2015) Giuseppe Murdaca et al. Expert Opinion On Drug Safety
- American Gastroenterological Association Institute Technical Review on Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
- (2015) Robert P. Perrillo et al. GASTROENTEROLOGY
- Safety of long-term biologic therapy in rheumatologic patients with a previously resolved hepatitis B viral infection
- (2015) Michele Barone et al. HEPATOLOGY
- Infliximab Does Not Worsen Outcomes During Flare-ups Associated with Cytomegalovirus Infection in Patients with Ulcerative Colitis
- (2015) Sylvie Pillet et al. INFLAMMATORY BOWEL DISEASES
- Response to Hepatitis A Vaccination in Immunocompromised Travelers
- (2015) Hannah M. Garcia Garrido et al. JOURNAL OF INFECTIOUS DISEASES
- Everolimus-Based Immunosuppression Therapy for BK Virus Nephropathy
- (2015) N. Polanco et al. TRANSPLANTATION PROCEEDINGS
- Risks of Herpes Zoster in Patients With Rheumatoid Arthritis According to Biologic Disease-Modifying Therapy
- (2015) Huifeng Yun et al. ARTHRITIS CARE & RESEARCH
- Varicella-Zoster Virus Infections in Patients Treated With Fingolimod
- (2015) Ann M. Arvin et al. JAMA Neurology
- The response to vaccination against influenza A(H1N1) 2009, seasonal influenza andStreptococcus pneumoniaein adult outpatients with ongoing treatment for cancer with and without rituximab
- (2014) Åke Berglund et al. ACTA ONCOLOGICA
- Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients
- (2014) R. San-Juan et al. CLINICAL MICROBIOLOGY AND INFECTION
- Hepatitis C virus reactivation in cancer patients in the era of targeted therapies
- (2014) Ozan Yazici WORLD JOURNAL OF GASTROENTEROLOGY
- Herpes Zoster and Tofacitinib Therapy in Patients With Rheumatoid Arthritis
- (2014) Kevin L. Winthrop et al. Arthritis & Rheumatology
- Risk of posttransplant lymphoproliferative disorder associated with use of belatacept
- (2013) S. T. Martin et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- mTOR Inhibitors Block Kaposi Sarcoma Growth by Inhibiting Essential Autocrine Growth Factors and Tumor Angiogenesis
- (2013) D. Roy et al. CANCER RESEARCH
- Association Between the Initiation of Anti–Tumor Necrosis Factor Therapy and the Risk of Herpes Zoster
- (2013) Kevin L. Winthrop et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Risk of herpes/herpes zoster during anti-tumor necrosis factor therapy in patients with rheumatoid arthritis. Systematic review and meta-analysis
- (2013) Helene Che et al. JOINT BONE SPINE
- Randomized Controlled Trial of Entecavir Prophylaxis for Rituximab-Associated Hepatitis B Virus Reactivation in Patients With Lymphoma and Resolved Hepatitis B
- (2013) Yi-Hsiang Huang et al. JOURNAL OF CLINICAL ONCOLOGY
- The risk of herpes zoster during biological therapy for psoriasis and other inflammatory conditions
- (2013) L. Adelzadeh et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Seroprotection After Hepatitis A Vaccination in Patients With Drug‐Induced Immunosuppression
- (2013) Wouter van den Bijllaardt et al. JOURNAL OF TRAVEL MEDICINE
- Prevention of cytomegalovirus following solid organ transplantation: A literature review
- (2013) Shanna Kowalsky et al. PEDIATRIC TRANSPLANTATION
- Herpes simplex virus encephalitis during treatment with etanercept
- (2013) Robbert H. J. Crusio et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Hepatitis B reactivation in chronic myeloid leukemia patients receiving tyrosine kinase inhibitor
- (2013) Guan-Min Lai WORLD JOURNAL OF GASTROENTEROLOGY
- Rituximab-Based Treatment, HCV Replication, and Hepatic Flares
- (2012) Evangelista Sagnelli et al. Clinical & Developmental Immunology
- Association Between Vaccination for Herpes Zoster and Risk of Herpes Zoster Infection Among Older Patients With Selected Immune-Mediated Diseases
- (2012) Jie Zhang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Is Cytomegalovirus Prophylaxis Dispensable in Patients Receiving an mTOR Inhibitor–Based Immunosuppression? A Systematic Review and Meta-Analysis
- (2012) Joachim Andrassy et al. TRANSPLANTATION
- Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy
- (2011) J.-L. Lan et al. ANNALS OF THE RHEUMATIC DISEASES
- Should we routinely treat patients with autoimmune/rheumatic diseases and chronic hepatitis B virus infection starting biologic therapies with antiviral agents? Yes
- (2011) Dimitrios Vassilopoulos European Journal of Internal Medicine
- Novel feedback inhibition of surface antigen synthesis by mammalian target of rapamycin (mTOR) signal and its implication for hepatitis B virus tumorigenesis and therapy
- (2011) Chiao-Fang Teng et al. HEPATOLOGY
- Women with Inflammatory Bowel Disease Do Not Receive Adequate Cervical Cancer Screening or Pregnancy Counseling
- (2011) Ruby Greywoode et al. INFLAMMATORY BOWEL DISEASES
- Hepatitis B Virus (HBV) Reactivation in Patients Receiving Tumor Necrosis Factor (TNF)-Targeted Therapy
- (2011) Roberto Pérez-Alvarez et al. MEDICINE
- Safety of biologic therapy in rheumatoid arthritis
- (2011) Robert S. Woodrick et al. Nature Reviews Rheumatology
- Five-year experience using sirolimus-based, calcineurin inhibitor-free immunosuppression in pediatric renal transplantation
- (2011) Leonard C. Hymes et al. PEDIATRIC TRANSPLANTATION
- Safety of anti-tumour necrosis factor agents in patients with chronic hepatitis C infection: a systematic review
- (2011) A. M. G. Brunasso et al. RHEUMATOLOGY
- New drugs beyond biologics in rheumatoid arthritis: the kinase inhibitors
- (2011) M. G. Bonilla-Hernan et al. RHEUMATOLOGY
- Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry
- (2010) D. Salmon-Ceron et al. ANNALS OF THE RHEUMATIC DISEASES
- Fatal Influenza A(H1N1) Respiratory Tract Infection in a Patient Having Psoriasis Treated With Infliximab
- (2010) Maxwell C. Kling et al. ARCHIVES OF DERMATOLOGY
- Immunosuppressive agents as risk factors for BK virus nephropathy: an overview and update
- (2010) Wana Manitpisitkul et al. Expert Opinion On Drug Safety
- Screening for cervical and breast cancer among women with inflammatory bowel disease
- (2010) Harminder Singh et al. INFLAMMATORY BOWEL DISEASES
- Kaposi's sarcoma in a psoriatic arthritis patient treated with infliximab
- (2010) Francesco Ursini et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Infections opportunistes non tuberculeuses au cours des traitements par les anti-TNFα
- (2010) I. Marie et al. REVUE DE MEDECINE INTERNE
- Review article: chronic viral infection in the anti-tumour necrosis factor therapy era in inflammatory bowel disease
- (2009) M. J. SHALE et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project
- (2009) K. R. Carson et al. BLOOD
- Herpes Simplex Encephalitis during Treatment with Tumor Necrosis Factor–α Inhibitors
- (2009) Russell D. Bradford et al. CLINICAL INFECTIOUS DISEASES
- Infections in Patients with Multiple Myeloma in the Era of High‐Dose Therapy and Novel Agents
- (2009) Marcio Nucci et al. CLINICAL INFECTIOUS DISEASES
- Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project
- (2009) Kenneth R Carson et al. LANCET ONCOLOGY
- Management guidelines for the use of alemtuzumab in chronic lymphocytic leukemia
- (2009) A Österborg et al. LEUKEMIA
- Cytomegalovirus colitis in a patient with Behcet’s disease receiving tumor necrosis factor alpha inhibitory treatment
- (2008) Ismail Sari et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Higher Incidence of Abnormal Pap Smears in Women With Inflammatory Bowel Disease
- (2007) Sunanda Kane et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More